SEP 10, 2026 · PHASE 3 TRIAL
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
ClinicalTrials.gov
This is a terminated Phase 3 trial registry record with no results posted; the study design and population are defined but no efficacy or safety data are available for assessment.
Reported
Planned enrollment137
PhasePhase 3
Primary outcome measure (Part A)Progression-free Survival (PFS) Per Investi…